<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="abstract"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur Psychiatry</journal-id><journal-id journal-id-type="iso-abbrev">Eur Psychiatry</journal-id><journal-id journal-id-type="publisher-id">EPA</journal-id><journal-title-group><journal-title>European Psychiatry</journal-title></journal-title-group><issn pub-type="ppub">0924-9338</issn><issn pub-type="epub">1778-3585</issn><publisher><publisher-name>Cambridge University Press</publisher-name><publisher-loc>Cambridge, UK</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11860402</article-id><article-id pub-id-type="doi">10.1192/j.eurpsy.2024.1306</article-id><article-id pub-id-type="other">EPV0653</article-id><article-id pub-id-type="pii">S0924933824013063</article-id><article-categories><subj-group subj-group-type="heading"><subject>Abstract</subject></subj-group><subj-group subj-group-type="section"><subject>e-Poster Viewing</subject></subj-group></article-categories><title-group><article-title>Transcranial magnetic stimulation for obsessive-compulsive disorder - preliminary results of an observational study</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Mangas Palma</surname><given-names>I.</given-names></name><xref rid="aff2916" ref-type="aff"/><xref rid="cor1158" ref-type="corresp">
<sup>*</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Borges</surname><given-names>J.</given-names></name><xref rid="aff2916" ref-type="aff"/></contrib><contrib contrib-type="author"><name><surname>Palha</surname><given-names>E.</given-names></name><xref rid="aff2916" ref-type="aff"/></contrib><contrib contrib-type="author"><name><surname>Salgado</surname><given-names>H.</given-names></name><xref rid="aff2916" ref-type="aff"/></contrib><contrib contrib-type="author"><name><surname>Alves</surname><given-names>P.</given-names></name><xref rid="aff2916" ref-type="aff"/></contrib><contrib contrib-type="author"><name><surname>Sousa Martins</surname><given-names>P.</given-names></name><xref rid="aff2916" ref-type="aff"/></contrib><contrib contrib-type="author"><name><surname>Moreira</surname><given-names>R.</given-names></name><xref rid="aff2916" ref-type="aff"/></contrib></contrib-group><aff id="aff2916">Servi&#x000e7;o de Psiquiatria, <institution>Centro Hospitalar Universit&#x000e1;rio de S&#x000e3;o Jo&#x000e3;o</institution>, <city>Porto</city>, <country>Portugal</country></aff><author-notes><corresp id="cor1158"><label>*</label>Corresponding author.</corresp></author-notes><pub-date publication-format="electronic" date-type="collection" iso-8601-date="2024-04"><month>4</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>27</day><month>8</month><year>2024</year></pub-date><volume>67</volume><issue seq="1281">Suppl 1</issue><issue-title content-type="special_issue">Abstracts of the 32nd European Congress of Psychiatry</issue-title><fpage>S630</fpage><lpage>S630</lpage><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>The Author(s)</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (<uri xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="S0924933824013063a.pdf"/><abstract><sec id="sec6961"><title>Introduction</title><p>Obsessive-compulsive disorder (OCD) has a high prevalence and causes a significative reduction in functionality and quality of life.</p><p>First and second line treatment is ineffective in a variable percentage of patients. In such cases transcranial magnetic stimulation (TMS) may be considered.</p></sec><sec id="sec6962"><title>Objectives</title><p>The goal of this study is to evaluate the impact of TMS treatment on obsessive-compulsive, anxious and depressive symptomatology in patients with OCD.</p></sec><sec id="sec6963"><title>Methods</title><p>A prospective observational study was conducted, including all patients diagnosed with OCD who underwent TMS in the Psychiatry department of Centro Hospitalar Universit&#x000e1;rio de S&#x000e3;o Jo&#x000e3;o since March 2023.</p><p>Symptomatology was assessed using the Yale Brown Obsessive-Compulsive Scale (Y-BOCS), the Hamilton Anxiety Rating Scale (HAM-A) and the Hamilton Depression Rating Scale (HAM-D) before and after treatment.</p><p>Statistical analysis was performed using the SPSS-Statistics program. A significance level of 0.05 was considered.</p></sec><sec id="sec6964"><title>Results</title><p>As of October 31, 2023, nine individuals with OCD completed treatment with TMS, 33% male and with a median age of 40 years (range 33-57).</p><p>The median Y-BOCS score pre-TMS was 30 (range 20-33) and post-TMS 28 (range 16-34). The median difference was 2.5 (range -5-14) and was not statistically significant (p=0.128).</p><p>
The median score on the HAM-A pre-TMS was 21 (range 9-41) and post-TMS 18 (range 11-24). The median difference was 0 points (range -4-21) and was not statistically significant (p=0.345).</p><p>The median HAM-D score pre-TMS was 26 (range 14-40) and post-TMS 19 (range 10-32). The median difference was 2.5 (range -3-20) and was not statistically significant (p=0.225).</p></sec><sec id="sec6965"><title>Conclusions</title><p>
Preliminary findings suggest that the impact of TMS on obsessive-compulsive, anxious, and depressive symptomatology in patients with OCD does not appear to be clinically or statistically significant.</p><p>Further results are necessary to confirm this trend.</p></sec><sec id="sec6966"><title>Disclosure of Interest</title><p>None Declared</p></sec></abstract><counts><page-count count="1"/></counts></article-meta></front></article>